MRI as Alternative to CBCT for the Assessment of Furcation Involvement in Molars
Launched by MEDICAL UNIVERSITY OF VIENNA · Oct 31, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to diagnose a dental condition called furcation involvement (FI) in molars, which occurs in patients with gum disease (periodontitis). Researchers want to compare magnetic resonance imaging (MRI) and cone beam computed tomography (CBCT) to see which method is better. MRI is appealing because it does not use harmful radiation, making it a safer option for patients. The study will involve 140 molars from patients who already need a CBCT and have been diagnosed with FI, allowing researchers to compare the results of both imaging techniques.
To participate in this trial, patients should be between the ages of 18 and 75 and have furcation involvement classified as grade II or III. Participants will undergo both CBCT and MRI scans during the study. Additionally, if any patients require further dental treatment, like surgery, researchers will also gather information from those procedures. It’s important to note that individuals who cannot undergo an MRI for medical reasons will not be included in the study. This trial aims to improve how we diagnose gum disease and potentially reduce the need for radiation exposure during dental imaging.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with FI grade II or III, patients who need a CBCT, not pregnant
- Exclusion Criteria:
- • Patients with contraindications to perform a MRI
About Medical University Of Vienna
The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported